1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61A603F8DF172734F00258BBE00410AF4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-endocrine-metabolic-disorders-medical-insights-management-team-structure-effectiveness-lessons-learned?opendocument
18
19opendocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Endocrine and Metabolic Disorders Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned

ID: 5837


Features:

21 Info Graphics

31 Data Graphics

370+ Metrics

15 Narratives


Pages/Slides: 64


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Endocrine and Metabolic Disorders Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned”

STUDY OVERVIEW

Medical Affairs teams in the endocrine and metabolic disorders segment operate within a complex landscape where effective dissemination of insights is critical to driving therapeutic impact. These teams face distinct challenges in building effective dissemination frameworks that ensure insights are timely, accurate, and impactful.

Best Practices, LLC conducted this research to explore how Medical Affairs teams within the endocrine and metabolic disorders space can structure their dissemination processes more effectively. The study provides benchmarks on successful dissemination models and uncovers lessons from industry leaders who have established effective information-sharing frameworks.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in endocrine and metabolic disorders medical insight generation: Insight Leaders (4 respondents) and Insight Majority (13 respondents).


KEY TOPICS

  • Structure of Endocrine and Metabolic Disorders Medical Insights and Dissemination Group
  • Disseminating Endocrine and Metabolic Disorders Insights: Tools, Activities and Effectiveness
  • Best Practices and Key Lessons Learned
  • Actionable Insights and Intelligence Gathering in Endocrine and Metabolic Disorders

KEY METRICS

  • Presence of a separate group that gathers and disseminates endocrine and metabolic disorders insights for Medical Affairs – Total benchmark class, Insight Leaders, and Insight Majority
  • Role of each of the groups within Medical Affairs for both gathering and disseminating endocrine and metabolic disorders insights – Total benchmark class, Insight Leaders, and Insight Majority
  • Roles of Medical Affairs sub-functions in gathering and disseminating endocrine and metabolic disorders insights – Insight Leaders and Insight Majority
  • Lead and support role of Medical Affairs groups in gathering and disseminating endocrine and metabolic disorders insights – Total benchmark class
  • Level of expertise of the person who is responsible for conveying endocrine and metabolic disorders medical insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Strengths and weaknesses of endocrine and metabolic disorders insights gathering and dissemination group structure
  • Breakdown of intelligence deliverables types in endocrine and metabolic disorders – Total benchmark class, Insight Leaders, and Insight Majority
  • Tools used by Endocrine and Metabolic Disorders Medical teams to deliver insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness and importance of digital tools used by the Endocrine and Metabolic Disorders Medical Affairs team to gather, evaluate, and disseminate intelligence – Total benchmark class, Insight Leaders, and Insight Majority
  • Additional methods used by Endocrine and Metabolic Disorders Medical Affairs teams to gather intelligence (beyond KOL and HCP engagement)

SAMPLE KEY FINDINGS

  • Medical Affairs Insight Leadership: Most companies rely on Field Teams (77%) and Medical Strategy (50%) to lead the insights process, leveraging their roles in direct data gathering and strategic input. Health Outcomes (36%) often adds a broader perspective by connecting clinical insights with real-world data, while Thought Leader Management and Scientific Publications (both 25%) contribute specialized insights through KOL engagement and literature analysis. This balanced approach taps into varied expertise, enhancing the depth and relevance of insights across functions.

METHODOLOGY

Best Practices, LLC engaged 17 executives from 14 leading life sciences companies specializing in endocrine and metabolic disorders for this research. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Communications; Pharmaceutical; Biotech; Health Care; Consumer Products; Biopharmaceutical; Clinical Research; Laboratories; Science


Companies Profiled:
ApotheCom; Boehringer Ingelheim; Eli Lilly and Company; Ipsen; Janssen; Lupin; Merck; Merck KGaA; Novartis; Novo Nordisk; Orchard Therapeutics; Sandoz; Sanofi; Thermo Fisher Scientific

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.